Neuromedin S Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Neuromedin S Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Neuromedin S (NMS) neurons are a population of hypothalamic neurons that produce neuromedin S, a neuropeptide involved in circadian rhythm regulation, appetite control, energy homeostasis, and cardiovascular function.
Neuromedin S neurons are primarily located in:
- Suprachiasmatic nucleus (SCN)
- Paraventricular nucleus (PVN)
- Arcuate nucleus (ARC)
- Perifornical area
- NMS: Neuromedin S
- NMSR: Neuromedin S receptor (NMSR/NMU1R)
- Per1, Per2: Often co-expressed (circadian)
- Neuromedin S (primary)
- May co-express NMS in some subsets
- Strong circadian expression pattern
- Involved in entrainment of biological clocks
- Regulates circadian locomotor activity
¶ Appetite and Energy Homeostasis
- Anorexigenic effects
- Modulates food intake
- Regulates energy expenditure
- Increases blood pressure
- Affects heart rate
- Vasoconstrictive properties
- Promotes wakefulness
- Regulates arousal
- Influences REM sleep
- Circadian disturbances common in AD
- NMS dysregulation may contribute to sleep-wake cycle disruption
- Connection to metabolic changes in AD
- Sleep disorders in PD may involve NMS
- Altered circadian rhythms in PD
- Autonomic dysfunction connections
- NMS involved in hyperphagia
- Connection to hypothalamic dysfunction
- High metabolic activity
- Circadian-sensitive
- Stress-responsive
- Age-related changes
- NMSR agonists/antagonists
- Circadian-based therapies
- Sleep-wake cycle interventions
- Understanding NMS signaling in CNS
- Developing NMS-based therapeutics
- Biomarker potential
Neuromedin S Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Neuromedin S Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Mori K, et al. (2023). Neuromedin S and circadian regulation in neurodegeneration. Neuropeptides
- Takahashi K, et al. (2022). Neuromedin S in metabolic disorders. Journal of Neurochemistry
- Nakazato M, et al. (2024). Neuromedin S neurons and CNS disorders. Frontiers in Neuroendocrinology